Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation

BACKGROUND: The duodenal-jejunal bypass liner (DJBL) is an endoscopic device designed to induce weight loss and improve glycemic control. The liner is licensed for a maximum implant duration of 12 months. It might be hypothesized that extension of the dwelling time results in added value. The goals...

Descripción completa

Detalles Bibliográficos
Autores principales: Betzel, B., Cooiman, M. I., Aarts, E. O., Janssen, I. M. C., Wahab, P. J., Groenen, M. J. M., Drenth, J. P. H., Berends, F. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946747/
https://www.ncbi.nlm.nih.gov/pubmed/30877567
http://dx.doi.org/10.1007/s00464-019-06752-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946747/
https://www.ncbi.nlm.nih.gov/pubmed/30877567
http://dx.doi.org/10.1007/s00464-019-06752-8

Ejemplares similares